Home  »  Finance   »  Catalent Inc. (NYSE: CTLT) Stock: Looks Like A Goo...

Catalent Inc. (NYSE: CTLT) Stock: Looks Like A Good Investment

Catalent Inc. (NYSE:CTLT) shares, rose in value on Wednesday, 05/24/23, with the stock price down by -1.81% to the previous day’s close as strong demand from buyers drove the stock to $37.44.

Actively observing the price movement in the last trading, the stock closed the session at $38.13, falling within a range of $36.22 and $37.68. The value of beta (5-year monthly) was 1.17 whereas the PE ratio was 16.57 over 12-month period. Referring to stock’s 52-week performance, its high was $115.33, and the low was $31.45. On the whole, CTLT has fluctuated by -11.61% over the past month.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


With the market capitalization of Catalent Inc. currently standing at about $5.83 billion, investors are eagerly awaiting this quarter’s results, scheduled for May 19, 2023. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.07, which is expected to increase to $0.84 for fiscal year $1.34 and then to about $1.86 by fiscal year 2024. Data indicates that the EPS growth is expected to be -65.60% in 2024, while the next year’s EPS growth is forecast to be 38.80%.

Analysts have estimated the company’s revenue for the quarter at $953.71 million, with a low estimate of $910.3 million and a high estimate of $1.02 billion. According to the average forecast, sales growth in current quarter could jump down -25.10%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2024, the company’s y-o-y revenues would reach $4.33 billion, representing a decrease of -10.40% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that CTLT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

17 analyst(s) have assigned their ratings of the stock’s forecast evaluation on a scale of 1.00-5.00 to indicate a strong buy to a strong sell recommendation. The stock is rated as a Hold by 7 analyst(s), 8 recommend it as a Buy and 0 called the CTLT stock Overweight. In the meantime, 2 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Overweight.

The stock’s technical analysis shows that the PEG ratio is about 3.78, with the price of CTLT currently trading nearly -6.25% and -27.97% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.30, while the 7-day volatility ratio is showing 6.13% which for the 30-day chart, stands at 6.05%. Furthermore, Catalent Inc. (CTLT)’s beta value is 1.22, and its average true range (ATR) is 2.97. The company’s stock has been forecasted to trade at an average price of $42.82 over the course of the next 52 weeks, with a low of $28.00 and a high of $60.00. Based on these price targets, the low is 25.21% off current price, whereas the price has to move -60.26% to reach the yearly target high. Additionally, analysts’ median price of $45.00 is likely to be welcomed by investors because it represents a decrease of -20.19% from the current levels.

A comparison of Catalent Inc. (CTLT) with its peers suggests the former has fared considerably weaker in the market. CTLT showed an intraday change of -1.81% in last session, and over the past year, it shrunk by -62.01%%. In comparison, Thermo Fisher Scientific Inc. (TMO) has moved lower at -2.74% on the day and was down -8.01% over the past 12 months. On the other hand, the price of Danaher Corporation (DHR) has fallen -1.00% on the day. The stock, however, is off -10.04% from where it was a year ago. Additionally, there is a gain of 0.10% for Vertex Pharmaceuticals Incorporated (VRTX) in last trading while the stock has seen an overall depriciation of 24.41%% over the past year. The PE ratio stands at 16.57 for Catalent Inc., compared to 33.27 for Thermo Fisher Scientific Inc., and 24.51 for Danaher Corporation. Other than that, the overall performance of the S&P 500 during the last trading session shows that it lost -0.73%. Meanwhile, the Dow Jones Industrial Slipped by -0.77%.

Data on historical trading for Catalent Inc. (NYSE:CTLT) indicates that the trading volumes over the past 10 days have averaged 6.27 million and over the past 3 months, they’ve averaged 4.19 million. According to company’s latest data on outstanding shares, there are 181.00 million shares outstanding.

Nearly 0.50% of Catalent Inc.’s shares belong to company insiders and institutional investors own 105.83% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.04 million shares as on Apr 27, 2023, resulting in a short ratio of 1.39. According to the data, the short interest in Catalent Inc. (CTLT) stood at 3.35% of shares outstanding as of Apr 27, 2023; the number of short shares registered in Mar 30, 2023 reached 6.4 million. The stock has fallen by -16.82% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CTLT stock heading into the next quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *